 |
|
|
| |
Pharmacokinetics of Temsavir, the Active Moiety of the Prodrug Fostemsavir, in Subjects with Hepatic Impairment
|
| |
| |
Reported by Jules Levin
IDWeek 2017™; October 4-8, 2017; San Diego, CA
K Moore,1M Magee,2P Ackerman,3H Sevinsky,4R Adamczyk,5J Karkas,6S Lubin,5P Ravindran,6T Eley,6C Llamoso3
1ViiV Healthcare, Research Triangle Park, NC; 2GlaxoSmithKline, Upper Merion, PA; 3ViiV Healthcare, Wallingford, CT; 4ViiV Healthcare, Upper Providence, PA; 5Bristol-Myers Squibb, Hopewell, NJ; 6Bristol Myers Squibb, Lawrenceville, NJ
|
| |
|
|
|
|
|
